Ushering in Neoadjuvant Immune Checkpoint Inhibitors for Mucosal Head and Neck Squamous Cell Carcinoma
- PMID: 40272822
- DOI: 10.1001/jamaoto.2025.0540
Ushering in Neoadjuvant Immune Checkpoint Inhibitors for Mucosal Head and Neck Squamous Cell Carcinoma
Comment on
-
Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma: A Review From the American Head and Neck Society.JAMA Otolaryngol Head Neck Surg. 2025 Jun 1;151(6):615-625. doi: 10.1001/jamaoto.2025.0410. JAMA Otolaryngol Head Neck Surg. 2025. PMID: 40272829 Review.
Publication types
LinkOut - more resources
Full Text Sources
